High ThroughputPARP in vivo Pharmacodynamic Assay|
Monday, February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings.
Vetter Development Service Chicago is Now Ready for Realizing Clinical Syringe Projects
Friday, December 12, 2014
Recent facility expansion offers new manufacturing options and additional filling capacity.
Imperial Innovations Leads £50 Million Series B Funding Round in Cell Medica
Tuesday, November 25, 2014
Cell Medica will use the investment capital to progress further the development of cellular immunotherapy products.
Clustering Effect Translates into Major Growth for BioPharma Specialist
Saturday, October 25, 2014
Company manages translation and linguistic validation projects.
New Accessories for the Mastersizer 3000 from Malvern Instruments
Friday, October 17, 2014
New accessories support smarter pharmaceutical particle size analysis.